Research and Markets: Inborn Gene or Chromosome Alterations - Pipeline Review, Developments & Analysis 2015

Research and Markets (http://www.researchandmarkets.com/research/jtnlql/inborn_gene_or) has announced the addition of the "Inborn Gene or Chromosome Alterations - Pipeline Review, 2015" report to their offering.

This Medical Devices sector report, Inborn Gene or Chromosome Alterations - Pipeline Review, 2015" provides an overview of genetic tests for Inborn Gene or Chromosome Alterations currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key genetic tests for Inborn Gene or Chromosome Alterations pipeline products.

Key Topics Covered:

• Extensive coverage of the genetic tests for Inborn Gene or Chromosome Alterations under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of genetic tests for Inborn Gene or Chromosome Alterations and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry
  

Benefits of this Report:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of genetic tests for Inborn Gene or Chromosome Alterations under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date
  

Report Structure:

1.1 List of Tables

1.2 List of Figures

2 Introduction

3 Products under Development

4 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies

5 Inborn Gene or Chromosome Alterations Companies and Product Overview

6 Inborn Gene or Chromosome Alterations- Recent Developments

7 Appendix

Companies Mentioned Include:

• AC-Gen Reading Life S.L.
• Admera Health, LLC
• Agena Bioscience, Inc
• Ariosa Diagnostics, Inc.
• Atomic International
• Baylor College of Medicine
• BCML GmbH
• CardioDx, Inc.
• Celula, Inc.
• Children's Hospital Boston
• China Medical Technologies, Inc.
• Da An Gene Co., Ltd.
• Dana-Farber Cancer Institute, Inc.
• University of Washington
• VitaPath Genetics, Inc.
• Xiamen Zeesan Biotech Co.,Ltd
• Yale University
  

For more information visit http://www.researchandmarkets.com/research/jtnlql/inborn_gene_or

View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005078/en/